Search results
Can-Fite's Namodenoson gains FDA Fast Track for liver cancer By Investing.com
Investing.com· 39 minutes agoS. Food and Drug Administration (FDA) for the treatment of advanced liver cancer, also known as...
Psychedelic-medicine stocks drop after ecstasy’s rocky day at the FDA
Market Watch· 43 minutes agoPrivately held Lykos Therapeutics is seeking FDA approval for the treatment combining talk therapy...
Cheese spread recall update as FDA sets risk level
Newsweek· 2 hours agoThe recalled cheese spreads were given the second-highest risk classification over concerns they may be contaminated with salmonella.
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks via Yahoo Finance· 22 hours agoAn FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to...
Psychedelic stocks fall as MDMA drug rejected (NASDAQ:MNMD)
Seeking Alpha· 2 hours agoDevelopers of psychedelic drugs sold off in the premarket after an FDA panel voted against marketing...
Be Bio’s haemophilia B treatment gains FDA orphan drug status
Pharmaceutical Technology via Yahoo Finance· 3 hours agoThe orphan drug designation reinforces the potential of this therapy and underscores the need for...
MDMA therapy wait goes on as FDA panel rejects Lykos’ PTSD treatment
Pharmaceutical Technology via Yahoo Finance· 3 hours agoUS-based Lykos’ application was for MDMA-assisted therapy, consisting of MDMA capsules in...
FDA panel rejects MDMA-based treatment for PTSD
The Hill via AOL· 11 hours agoA potential treatment for post-traumatic stress disorder using the psychedelic MDMA was overwhelmingly rejected by a panel of federal regulators on...
QIAGEN's (QGEN) New Launch Expands US Syndromic Testing Menu
Zacks via Yahoo Finance· 1 hour ago-Dx Gastrointestinal Panel 2 in the United States following the recent FDA clearance of the...
Baird maintains MindMed stock at Outperform By Investing.com
Investing.com· 36 minutes agoThe endorsement follows the scrutiny MindMed's shares faced during the FDA Advisory Committee...